Introduction

Tdap stands for tetanus (T), diphtheria, (D), and pertussis (aP). The Tdap vaccine became available in 2005 for older children and adults. Before 2005, there was no pertussis booster shot for anybody over 6 years of age.

Tdap is different than the DTaP vaccine (diphtheria, tetanus, and whooping cough), which is given to infants and children in five doses, starting at 2 months of age. Tdap is only for those above the age of 7 years.

What are the possible side effects of the Tdap vaccine?

Every vaccine comes with a chance of side effects, and the Tdap vaccine is no exception. Fortunately, reported side effects with Tdap are generally mild and go away on their own.

• Mild to moderate side effects may include:
• Mild pain, redness, or swelling at the shot site
• Tiredness
• Body aches
• Headache
• Nausea, vomiting, or diarrhea
• Mild fever
• Swelling of the entire arm in which the vaccine was given

Severe problems after the Tdap vaccine are rarely reported, but may include:

• Severe swelling, pain, or bleeding in the arm where the shot was given
• A very high fever
• Signs of allergic reaction within a few minutes to a few hours of vaccine, which may include hives, swelling of the face or throat, difficulty breathing, rapid heartbeat, and dizziness.

Tdap vaccine during pregnancy

The Centers for Disease Control and Prevention (CDC) Trusted Source recommends that all women receive a Tdap vaccine during the 27th and 36th week of pregnancy.

Once you have protection from the vaccine, you’re less likely to pass whooping cough to your newborn. Infants are more likely to develop severe, life threatening complications from pertussis.

Vaccine schedule

Adolescents age 11 to 12: 1 dose Tdap

Pregnancy: 1 dose Tdap during each pregnancy, preferably at 27 to 36 weeks.

Catch-up vaccination

• Adolescents age 13 to 18 who haven’t received Tdap: 1 dose Tdap, then a Td (to prevent tetanus and diphtheria) or Tdap booster every 10 years
• Persons age 7 to 18 who aren’t fully vaccinated with DTaP: 1 dose Tdap as part of the catch-up series (preferably the first dose); if additional doses are needed, use Td or Tdap
• Tdap administered at age 7 to 10:
• Children age 7 to 9 who receive Tdap should receive the routine Tdap dose at age 11 to 12.
• Children age 10 who receive Tdap don’t need to receive the routine Tdap dose at age 11 to 12.

Who should get TDAP vaccine

• If you’re age 18 or older, the cdctrusted Source recommends that you get a dose of Tdap in place of your next Td (tetanus and diphtheria) booster if:
• You’ve never gotten the Tdap shot
• You don’t remember if you’ve ever had the Tdap shot
• A Td booster is usually given every 10 years with a single injection in the upper arm.
• You anticipate having close contact with an infant younger than 12 months; ideally, you should get the shot at least 2 weeks before holding an infant
• You’re pregnant; pregnant women should get a Tdap booster with every pregnancy

Conclusion

 Our Journal is planning to release a year end special issue has announced almost 50% discount on article publication charges to celebrate its journey for publishing articles with in the short time.

 A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.

Manuscripts can be forwarded to the Editorial Office at autoimmunedis@eclinicalsci.com

How we work:

• After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
• A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
• Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Color Art: In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

Media Contact:
John Kimberly
Editorial Manager
Journal of Vaccines & Vaccination
Email: jvv@scholarlypub.com